Inc42·
Thyrocare Q2 Profit Slips 68% YoY To ₹15 Cr Due To ₹45 Cr Exceptional Expense
PharmEasy-backed Thyrocare’s net profit for the September quarter (Q2 FY27) slumped 68.2% year-on-year (YoY) to ₹15.2 Cr from ₹47.8 Cr…
Read at Inc42 →
PharmEasy-backed Thyrocare’s net profit for the September quarter (Q2 FY27) slumped 68.2% year-on-year (YoY) to ₹15.2 Cr from ₹47.8 Cr…

<iframe src="https://hindustansphere.com/embed/cluster/a419f5719290f3a8fd85fa3b60fb6229cc71e480" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Thyrocare Q2 Profit Slips 68% YoY To ₹15 Cr Due To ₹45 Cr Exceptional Expense"></iframe>